|
Name |
Geoxantether B
|
Molecular Formula | C24H24O3 | |
IUPAC Name* |
2-[(2,7-dimethyl-9H-xanthen-4-yl)methoxymethyl]-4-methylphenol
|
|
SMILES |
CC1=CC2=C(C=C1)OC3=C(C2)C=C(C=C3COCC4=C(C=CC(=C4)C)O)C
|
|
InChI |
InChI=1S/C24H24O3/c1-15-4-6-22(25)20(9-15)13-26-14-21-11-17(3)10-19-12-18-8-16(2)5-7-23(18)27-24(19)21/h4-11,25H,12-14H2,1-3H3
|
|
InChIKey |
NFLXOLFVSCCVDT-UHFFFAOYSA-N
|
|
Synonyms |
Geoxantether B
|
|
CAS | NA | |
PubChem CID | 139588421 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 360.4 | ALogp: | 5.3 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 38.7 | Aromatic Rings: | 4 |
Heavy Atoms: | 27 | QED Weighted: | 0.495 |
Caco-2 Permeability: | -5.294 | MDCK Permeability: | 0.00002060 |
Pgp-inhibitor: | 0.911 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.537 |
Blood-Brain-Barrier Penetration (BBB): | 0.115 | Plasma Protein Binding (PPB): | 100.15% |
Volume Distribution (VD): | 0.514 | Fu: | 1.41% |
CYP1A2-inhibitor: | 0.161 | CYP1A2-substrate: | 0.907 |
CYP2C19-inhibitor: | 0.825 | CYP2C19-substrate: | 0.252 |
CYP2C9-inhibitor: | 0.41 | CYP2C9-substrate: | 0.149 |
CYP2D6-inhibitor: | 0.144 | CYP2D6-substrate: | 0.928 |
CYP3A4-inhibitor: | 0.201 | CYP3A4-substrate: | 0.854 |
Clearance (CL): | 8.968 | Half-life (T1/2): | 0.456 |
hERG Blockers: | 0.048 | Human Hepatotoxicity (H-HT): | 0.129 |
Drug-inuced Liver Injury (DILI): | 0.297 | AMES Toxicity: | 0.305 |
Rat Oral Acute Toxicity: | 0.136 | Maximum Recommended Daily Dose: | 0.938 |
Skin Sensitization: | 0.93 | Carcinogencity: | 0.611 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.915 |
Respiratory Toxicity: | 0.096 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003683 | 0.617 | D03DJL | 0.272 | ||||
ENC004017 | 0.336 | D00NJL | 0.270 | ||||
ENC004018 | 0.325 | D0BZ7W | 0.265 | ||||
ENC000877 | 0.325 | D04NQI | 0.265 | ||||
ENC004016 | 0.325 | D0AZ8C | 0.259 | ||||
ENC001921 | 0.325 | D05HSC | 0.250 | ||||
ENC006146 | 0.324 | D02FCQ | 0.248 | ||||
ENC006147 | 0.313 | D0Y7PG | 0.248 | ||||
ENC004019 | 0.308 | D04YMH | 0.245 | ||||
ENC002740 | 0.308 | D06XZW | 0.244 |